Study of CYR-101 in Patients With Schizophrenia
Clinical trial NCT00861796 · COMPLETED
Trial details
- NCT number
- NCT00861796
- Sponsor
- Cyrenaic Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2010-05-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.